Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Real-world insights into genomic reprogramming during CAR-T cell manufacturing in India. Local targets link to admitted publications; unresolved targets remain external evidence.
Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological Malignancies
10.1002/cam4.5551 · 2023 · External reference
Expanding the therapeutic reach of chimeric antigen receptor T-cells and bispecific T-cell engagers across solid tumors
10.1200/po-24-00753 · 2025 · External reference
Challenges and solutions to superior chimeric antigen receptor-T design and deployment for B-cell lymphomas
10.1111/bjh.19001 · 2023 · External reference
Leukapheresis for CAR-T cell production and therapy
10.1016/j.transci.2023.103828 · 2023 · External reference
Comparison of axicabtagene ciloleucel and tisagenlecleucel patient CAR-T cell products by single-cell RNA sequencing
10.1136/jitc-2025-011807 · 2025 · External reference
Surveying local CAR T-cell manufacturing processes to facilitate standardization and expand accessibility
10.1186/s12967-025-06400-x · 2025 · External reference
Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remission
10.1038/s41586-024-07762-w · 2024 · External reference
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
10.1038/s41591-018-0010-1 · 2018 · External reference
Improving CAR T-cell persistence
10.3390/ijms221910828 · 2021 · External reference
Integrative bulk and single-cell profiling of premanufacture T-cell populations reveals factors mediating long-term persistence of CAR T-cell therapy
10.1158/2159-8290.cd-20-1677 · 2021 · External reference
Autophagy inhibition prevents CAR-T exhaustion and terminal differentiation via TCF7 accumulation
10.1182/blood-2023-189441 · 2023 · External reference
Common trajectories of highly effective CD19-specific CAR T cells identified by endogenous T-cell receptor lineages
10.1158/2159-8290.cd-21-1508 · 2022 · External reference
BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells
10.1038/s41590-021-00964-8 · 2021 · External reference
The transcription factor BATF pioneers the differentiation program of effector CD8+ T cells through the interaction with IRF4
10.1016/j.celrep.2025.116129 · 2025 · External reference
PHGDH at the crossroads: metabolic plasticity, metastatic paradoxes, and therapeutic reconnaissance in cancer
10.1186/s12929-025-01205-y · 2026 · External reference
Dissecting the tumor-immune landscape in chimeric antigen receptor T-cell therapy: Key challenges and opportunities for a systems immunology approach
10.1158/1078-0432.ccr-19-3888 · 2020 · External reference
Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments
10.1186/s12967-023-04292-3 · 2023 · External reference
